Chan Xie Selected Research

Chan Xie Research Topics

Disease

13	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 01/2012
7	Hepatitis B 01/2022 - 04/2009
5	Acute-On-Chronic Liver Failure 01/2022 - 01/2016
5	Neoplasms (Cancer) 11/2019 - 01/2012
4	Chronic Hepatitis B 02/2022 - 09/2011
4	Neoplasm Metastasis (Metastasis) 08/2021 - 01/2018
3	Fibrosis (Cirrhosis) 04/2022 - 09/2011
3	Carcinogenesis 07/2013 - 06/2011
2	End Stage Liver Disease 01/2022 - 09/2011
2	Liver Diseases (Liver Disease) 01/2019 - 11/2008
2	Liver Failure 03/2014 - 09/2011
1	Disease Progression 02/2022
1	Hepatic Encephalopathy 01/2022
1	Bone Diseases (Bone Disease) 02/2021
1	Macular Degeneration (Age-Related Maculopathy) 02/2021
1	Congenital Abnormalities (Deformity) 01/2019
1	Infections 01/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019
1	Hepatitis 01/2015

Drug/Important Bio-Agent (IBA)

5	CateninsIBA 08/2021 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2012
3	BilirubinIBA 01/2022 - 09/2011
2	tenofovir alafenamideIBA 02/2022 - 01/2021
2	Galectin 3 (LGALS3)IBA 08/2021 - 02/2021
2	Transcription Factor 7-Like 2 ProteinIBA 03/2021 - 11/2019
2	Pharmaceutical PreparationsIBA 02/2021 - 01/2019
2	Therapeutic UsesIBA 01/2021 - 01/2012
2	Complement C2 (Complement Component 2)IBA 10/2020 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 11/2019 - 01/2018
2	Biological ProductsIBA 11/2019 - 01/2012
1	InterferonsIBA 02/2022
1	Tenofovir (Viread)FDA Link 02/2022
1	FumaratesIBA 02/2022
1	Hepatitis B e AntigensIBA 02/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 02/2022
1	entecavir FDA Link 02/2022
1	NucleotidesIBA 02/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	NitrogenIBA 01/2022
1	CreatinineIBA 01/2022
1	Antiviral Agents (Antivirals)IBA 10/2021
1	LectinsIBA 02/2021
1	Verteporfin (Visudyne)FDA Link 02/2021
1	UbiquitinIBA 02/2021
1	sodium-bile acid cotransporterIBA 01/2021
1	nasIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	beta CateninIBA 11/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	NucleosidesIBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2019
1	Interleukin-27 (Interleukin 27)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 11/2018
1	enhancer-binding protein AP-4IBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	Complement System Proteins (Complement)IBA 01/2016
1	VaccinesIBA 08/2015
1	Prothrombin (Factor II)IBA 01/2015
1	Dinoprostone (PGE2)FDA Link 03/2014
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2013
1	ParaffinIBA 01/2012
1	Alanine Transaminase (SGPT)IBA 09/2011
1	AlbuminsIBA 09/2011
1	methionylmethylsulfonium chloride (MMSC)IBA 09/2011
1	AgarIBA 06/2011
1	Epidermal Growth Factor (EGF)IBA 04/2009

Therapy/Procedure

2	Therapeutics 02/2022 - 11/2008
2	Transplantation 08/2021 - 09/2011
1	Immunotherapy 10/2022
1	Liver Transplantation 04/2022
1	Plasma Exchange 01/2022